[Discussion] we are measuring HPLC at the wrong time and calling it noise
The title is the argument: we are measuring HPLC at the wrong time and calling it noise. Here is the rest of it.
Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.
Reading a trace posted here, in the order I actually look at things.
Axes first — if the wavelength and the time axis are not labelled, I stop. Then the baseline: where has it been drawn, and does the drawing absorb anything. Then peak shape: fronting, tailing, a shoulder that never resolves. Then the blank, if one was run, for carryover.
Only after all of that do I look at the percentage, and by then I usually know how much weight it deserves. The number is the last thing on the page and the first thing everybody argues about, which is exactly backwards.
The system suitability argument, since it comes up whenever somebody posts a number without one.
Before the sample result means anything, the instrument has to be shown to be fit that day: replicate injections with an acceptable RSD on area, a tailing factor inside limits, adequate plate count, and a resolution check between the pair you care about.
None of that is exotic and all of it is routine in a laboratory that reports for a living. Its absence does not mean a number is wrong; it means the number is unanchored, and unanchored numbers should not be quoted to two decimal places on this board.
Happy to answer the boring questions. Those are usually the ones worth asking.
best — the order this archive was captured in
Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.
[removed by moderator]
a blank injection between samples costs four minutes and settles most arguments
Same view — reporting the gradient is what makes a result checkable rather than merely stated.
What wavelength, and what was the gradient?
baseline choice is a decision, not a measurement
axis labels or the trace is decoration
Trace posted without axis labels — asked for a relabelled version rather than removing it.
Trace posted without axis labels — asked for a relabelled version rather than removing it.
Adding one practical thing — run the blank. It answers this before anyone has to argue about it.
Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.
the column has a history and it shows in the peak shape
Sent the same vial to PeptideMeter and VendorInvestigate. 98.1% against a claimed 98.0%. The difference was the gradient, not the material.
LC-MS for identity, UV for relative quantity
A shoulder that does not baseline-resolve cannot be quantified honestly. You can report it as an unresolved shoulder, which is useful information, or you can develop the method until it resolves.
I would not blame the sample yet. Everything you have described is consistent with the column rather than the vial.
Agreed. Two analysts, one trace, two integration choices, and a spread that has nothing to do with the vial.
System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.
Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.
Started reporting my own integrations with the baseline choice stated. Arguments in my threads dropped by about half.
That is area percent, not mass percent. The trace cannot give you the second one.
Agreed, and it is why GL Biochem printing the column and gradient on the certificate is genuinely useful rather than decorative.
Agreed, and it is why GL Biochem printing the column and gradient on the certificate is genuinely useful rather than decorative.
This is the whole methodological point of the board in one line.
Did you run a blank between injections?
What did system suitability look like on that sequence?
report the method or do not report the number
report the method or do not report the number
rosa_sandvik is right — the integration choice is a decision and it should be stated alongside the result.
Correction: that is a tailing factor, not a plate count. Different diagnostics for different problems.
This. A shoulder that does not baseline-resolve is a question, not a quantity.
Same method at both labs, or two different gradients?
BCH sent me the column, the gradient and the theoretical mass without being asked. That is a short list and they are on it.
- 1System suitability — repeat injections, tailing factor, plate count, RSD on…14 comments in this branch · started by u/georgi_tamm
- 2axis labels or the trace is decoration8 comments in this branch · started by u/coa_janitor